HOTH News and Press, Hoth Therapeutics Inc. From 06/11/19

June 11, 2019 Palm Beach, FL – June 11, 2019 – Recent reports by industry specialists show that the Atopic Dermatitis Drugs Market Size Worth $6.41 Billion By 2022, exhibiting a CAGR of 6.6% during the forecast period. This is an increase from the 2016 market reven...

NEW YORK , June 10, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis-also known as eczema-as well as dermatological and chronic wound disorders,...

Hoth Therapeutics (NASDAQ: HOTH ) has formed a subsidiary, Hoth Therapeutics Australia Pty Ltd, in anticipation to perform clinical trials for atopic dermatitis. More news on: Spherix Incorporated, Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...

NEW YORK , June 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis-also known as eczema-as well as dermatological and chronic wound disorders,...

Gainers:  ReWalk Robotics (NASDAQ: RWLK ) +126% . Genocea Biosciences (NASDAQ: GNCA ) +14% . Dean Foods (NYSE: DF ) +13% . RAVE Restaurant Group (NASDAQ: RAVE ) +11% . Medley Management (NYSE: MDLY ) +10% . Neon Therapeutics (NASDAQ: NTGN ) +10% . Allena Pharmaceuticals (NASDAQ:...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) was in the red last week, dropping from 3,279.52 points on Tuesday (May 28) to 3,167.47 points as of 1:36 p.m. EDT on Friday (May 31). Despite the index’s dip, a number of NASDAQ biotech and pharma stocks still had notable share price...

NEW YORK , May 29, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chron...

Ultra-thinly traded nano cap Hoth Therapeutics ( HOTH +15.5% ) is up on triple normal volume, albeit on turnover of only 50K shares, in reaction to its announced term sheet with Zylö Therapeutics aimed at co-developing a treatment for cutaneous lupus erythematosus (CLE), a chronic...

NEW YORK , May 14, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chroni...

The following slide deck was published by Hoth Therapeutics, Inc. in conjunction with this Read more ...